IN VIVO CANCER IMAGING EXPLORATORY/DEVELOPMENTAL GRANTS

The summary for the IN VIVO CANCER IMAGING EXPLORATORY/DEVELOPMENTAL GRANTS Federal Grant is detailed below. It contains information such as the Catalog of Federal Domestic Assistance (CFDA) number, who is eligible for the grant, how much grant money will be awarded, important deadlines, and a sampling of similar government grants. Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed in the Grant Announcement Contact section. If these sections are incomplete, please visit the website of the government agency that is offering this grant.


	Federal Grant Title:	IN VIVO CANCER IMAGING EXPLORATORY/DEVELOPMENTAL GRANTS
	CFDA Number:	93.394
	CFDA Description:	Cancer Detection and Diagnosis Research
	Federal Agency Name:	National Institutes of Health
	Category of Funding Activity:	Education Health
	Category Explanation:	Information not provided
	Opportunity Category:	Discretionary
	Funding Opportunity Number:	PA-04-045
	Document Type:	Modification to Previous Grants Notice
	Funding Instrument Type:	Grant
	Posted Date:	Aug 12, 2005
	Creation Date:	Aug 12, 2005
	Original Closing Date for Applications:	Multiple Receipt Dates - See Link to Full Announcement for details.
	Current Closing Date for Applications:	Information not provided
	Archive Date:	Nov 02, 2006
	Expected Number of Awards:	Information not provided
	Estimated Total Program Funding:	Information not provided
	Federal Grant Award Ceiling:	Information not provided
	Federal Grant Award Floor:	Information not provided
	Cost Sharing or Matching Requirement:	No

Applicants Eligible for this Grant: State governments County governments City or township governments Special district governments Independent school districts Public and State controlled institutions of higher education Native American tribal governments (Federally recognized) Public housing authorities/Indian housing authorities Native American tribal organizations (other than Federally recognized tribal governments) Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education Private institutions of higher education For profit organizations other than small businesses Small businesses Others (see text field entitled "Additional Information on Eligibility" for clarification)
Additional Information on Eligibility: Eligible agencies of the Federal government Foreign institutions are eligible to apply
Grant Description: The Cancer Imaging Program (CIP) of the Division of Cancer Treatment and Diagnosis (DCTD) solicits exploratory/developmental (R21) applications that articulate exploratory/developmental research focused on in vivo cancer imaging. The R21 mechanism will provide investigators at all career levels with a defined level of funding adequate for the initial development and/or feasibility testing of high impact concepts. Topics considered responsive to this Program Announcement will cover the entire spectrum of in vivo cancer imaging research, from basic discovery of new cancer imaging agents and technologies, through pre-clinical testing and validation, to the early feasibility testing of those novel agents and technologies in small clinical trials.
Link to Full Grant Announcement: http://grants.nih.gov/grants/guide/pa-files/PA-04-045.html http://grants.nih.gov/grants/guide/pa-files/PA-04-045.html
Grant Announcement Contact: Webmaster, NIH, Webmaster, Phone not available, Fax not available, Email FBOWebmaster@mail.nih.gov FBOWebmaster@mail.nih.gov Webmaster, NIH
Similar Government Grants: • Early Phase Clinical Trials in Imaging and Image-Guided Interventions (R21); • Strategic Partnering to Evaluate Cancer Signatures [SPECS II] (U01); • Quantitative Imaging for Evaluation of Responses to Cancer Therapies (U01); • SBIR Phase IIB Bridge Awards to Accelerate the Development of Cancer Therapeutics, Imaging Technolog...; • Opportunity RFA-AI-10-030; • Image-Guided Cancer Interventions (STTR [R41/R42]); • An SBIR Initiative for Image-Guided Cancer Interventions (R43/R44); • Exploratory Studies in Cancer Detection, Diagnosis, and Prognosis; • PHASED APPLICATION AWARDS IN CANCER PROGNOSIS AND PREDICTION; • IN VIVO CELLULAR AND MOLECULAR IMAGING CENTERS (ICMICs)